Mount Sinai has developed a machine learning model forecasting the cardiovascular risk impact of CPAP in obstructive sleep apnea patients.
Key Details
- 1Mount Sinai team used machine learning to analyze data from over 2,600 patients in the SAVE trial.
- 2The model estimates whether CPAP usage will benefit or harm individual cardiovascular risk profiles.
- 3Substantial differences in treatment response were discovered across patient subgroups, with up to 100-fold differences in outcomes.
- 4Model is based on 23 selected baseline predictors from over 100 sleep and health variables.
- 5Findings highlight potential for precision medicine in treating sleep apnea and associated cardiovascular risks.
Why It Matters
This study marks a step towards personalized medicine using AI, supporting tailored treatment plans in sleep medicine and cardiovascular disease. The approach underscores the value of advanced analytics in stratifying risk and improving patient outcomes, reflecting broader trends toward individualized AI-powered decision support in clinical settings.
Source
EurekAlert
Related News
•EurekAlert
AI Model Accurately Predicts Recurrence After Barrett’s Esophagus Therapy
Researchers created an AI tool that predicts recurrence of Barrett’s esophagus following endoscopic eradication therapies with greater than 90% accuracy.
•EurekAlert
Hybrid AI Model Enhances Early Lung Cancer Detection on CT Scans
Researchers developed a hybrid AI model that significantly improves early lung cancer detection from CT scans.
•EurekAlert
NIH Invests Additional $12.6M in USC-Led Imaging AI for Alzheimer's
NIH has renewed and expanded its support for a USC-led consortium developing AI to decode and treat Alzheimer's using imaging and genomic data.